The statement by the Friends of the COVID-19 Vaccine Global Access (COVAX) Facility came as part of ongoing worldwide efforts to launch a multilateral platform aimed at securing safe and fair access and distribution of COVID-19 vaccines.
The Philippines' purchase and distribution of Covid-19 vaccines can only be made starting the second quarter of 2021 as delays hit the review of possible candidates, an official said.
The statement comes as a study released by Oxfam, an global confederation of non-government organisations, showed a group of wealthy countries representing just 13 per cent of the world population have bought up over half the promised Covid-19 vaccine stocks.
According to the Commission's estimate, supply could far outstrip demand next year.
Depending on the success of the trials, Dr Rahman said that the COVID-19 vaccine will be available in the country between April and June.
The undersecretary said the meeting with the Russian Embassy "went well".
The EU money is used for down payments to vaccine makers and covers mostly development and production costs.
While the initial payment would be lost if a vaccine proved ineffective or unsafe, the deals allow the European Union to secure doses in advance with a commitment to make the larger payments at a later stage if vaccines are successful.
The company's CEO, Stephane Bancel said that the trial will likely yield enough data to know whether the vaccine is effective in a Thursday Squawkbox interview.
The British-Swedish company is not the only pharma giant to release its blueprint to public in midst of research to develop a potential Covid-19 vaccine candidate as the virus surges across the world.
Foreign Minister Winston Peters on Monday said New Zealand had signed an agreement to invest an initial $27m in the COVAX facility's efforts to create a Covid-19 vaccine.
The Covax Facility is about to set a precedent of multilateral cooperation and solidarity, said the FOF statement.
The Commission has privately warned EU governments not to buy vaccines through COVAX, European officials have told Reuters, as the global procurement scheme could result in the EU having a small share of shots as its population is only 450 million of the world's almost 8 billion people.